Wan Xiang
Hubei Key Laboratory Of Urological Diseases
Wuhan, China
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Hypoxia-Driven Immune Escape in Clear Cell Renal Cell Carcinoma: A Prognostic Model and Dual-Functional Biomarker PLOD2 for Immunotherapy Stratification.
Journal: Journal of Cancer
Published: March 21, 2025
Epigenetic insights into minimal residual disease detection in cancer.
Journal: Genes & diseases
Published: March 01, 2025
E3 ubiquitin ligase TRIM2 identified as a novel suppressor of CYP11B2 and aldosterone production.
Journal: Cellular and molecular life sciences : CMLS
Published: September 19, 2024
ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3β/c-Myc signaling pathway.
ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3β/c-Myc signaling pathway.
Journal: Journal of Cancer
Published: February 21, 2024
USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer.
Journal: Cell death & disease
Published: June 05, 2023
Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation.
Journal: Cell death & disease
Published: May 22, 2023
Acyl-coenzyme A: cholesterol acyltransferase inhibitor avasimibe suppresses tumorigenesis and induces G1-phase cell-cycle arrest by activating PPARγ signaling pathway in bladder cancer.
Journal: Journal of Cancer
Published: February 25, 2023
UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT.
Journal: International journal of biological sciences
Published: February 23, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026